Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

Resat Cinar; Abhishek Basu; Muhammad Arif; Joshua K. Park; Charles N. Zawatsky; Ben Long G. Zuo; Mei Xing G. Zuo; Kevin J. O’Brien; Molly Behan; Wendy Introne; Malliga R. Iyer; William A. Gahl; May Christine V. Malicdan; Bernadette R. Gochuico

doi:10.1164/rccm.202406-1143RL

Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

Resat Cinar
, Abhishek Basu
, Muhammad Arif
, Joshua K. Park
, Charles N. Zawatsky
, Ben Long G. Zuo
, Mei Xing G. Zuo
, Kevin J. O’Brien
, Molly Behan
, Wendy Introne
, Malliga R. Iyer
, William A. Gahl
, May Christine V. Malicdan
, Bernadette R. Gochuico

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	650-654
Number of pages	5
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	211
Issue number	4
DOIs	https://doi.org/10.1164/rccm.202406-1143RL
State	Published - Apr 2025
Externally published	Yes

Access to Document

10.1164/rccm.202406-1143RL

Cite this

Cinar, R., Basu, A., Arif, M., Park, J. K., Zawatsky, C. N., Zuo, B. L. G., Zuo, M. X. G., O’Brien, K. J., Behan, M., Introne, W., Iyer, M. R., Gahl, W. A., Malicdan, M. C. V., & Gochuico, B. R. (2025). Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 211(4), 650-654. https://doi.org/10.1164/rccm.202406-1143RL

@article{5a5b29ef5f3a4dcd9fbe9b55c1892d65,

title = "Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis",

author = "Resat Cinar and Abhishek Basu and Muhammad Arif and Park, \{Joshua K.\} and Zawatsky, \{Charles N.\} and Zuo, \{Ben Long G.\} and Zuo, \{Mei Xing G.\} and O{\textquoteright}Brien, \{Kevin J.\} and Molly Behan and Wendy Introne and Iyer, \{Malliga R.\} and Gahl, \{William A.\} and Malicdan, \{May Christine V.\} and Gochuico, \{Bernadette R.\}",

year = "2025",

month = apr,

doi = "10.1164/rccm.202406-1143RL",

language = "English",

volume = "211",

pages = "650--654",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "Oxford University Press",

number = "4",

}

Cinar, R, Basu, A, Arif, M, Park, JK, Zawatsky, CN, Zuo, BLG, Zuo, MXG, O’Brien, KJ, Behan, M, Introne, W, Iyer, MR, Gahl, WA, Malicdan, MCV & Gochuico, BR 2025, 'Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis', American Journal of Respiratory and Critical Care Medicine, vol. 211, no. 4, pp. 650-654. https://doi.org/10.1164/rccm.202406-1143RL

TY - JOUR

T1 - Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

AU - Cinar, Resat

AU - Basu, Abhishek

AU - Arif, Muhammad

AU - Park, Joshua K.

AU - Zawatsky, Charles N.

AU - Zuo, Ben Long G.

AU - Zuo, Mei Xing G.

AU - O’Brien, Kevin J.

AU - Behan, Molly

AU - Introne, Wendy

AU - Iyer, Malliga R.

AU - Gahl, William A.

AU - Malicdan, May Christine V.

AU - Gochuico, Bernadette R.

PY - 2025/4

Y1 - 2025/4

UR - https://www.scopus.com/pages/publications/105001849535

U2 - 10.1164/rccm.202406-1143RL

DO - 10.1164/rccm.202406-1143RL

M3 - Letter

C2 - 39841973

AN - SCOPUS:105001849535

SN - 1073-449X

VL - 211

SP - 650

EP - 654

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

IS - 4

ER -